HealthQuill Serious Chronic Diseases
Novo Nordisk plans to invest 42 million Danish kroner ($6 billion) in Denmark to create new capacities for making active pharmaceutical ingredients and expand its portfolio within serious chronic diseases.
Drugs Health Pharma

Novo Nordisk plans $6 billion investment to expand in Denmark

HQ Team November 10, 2023: Novo Nordisk plans to invest 42 million Danish kroner ($6 billion) in Denmark to create new capacities for.

Read More